Search - tctmd.com

Displaying 1 - 12 of 12

Sort: Relevancy | Date

News Daily News

Brachytherapy Remains an Option for DES In-Stent Restenosis

Yael L. Maxwell

January 12, 2023

News Daily News

Volume-Outcome Relationship Questioned in CHIP PCI for Stable Angina

Todd Neale

February 13, 2020

News Conference News LINC 2020

Algorithm Aims to Help Operators Pair Laser Settings With PAD Lesion Type

L.A. McKeown

February 06, 2020

News Daily News

CTO PCI: Lower Success, More Complications vs Other Complex PCI

Yael L. Maxwell

November 13, 2019

News Conference News

PREPARE-CALC Shows Benefits of Rotational Atherectomy

TCT Daily Staff

October 01, 2018

News Daily News

REAL PTX: Head-to-Head DCB, DES Data in PAD Show Trend Favoring Stenting at 36 Months

L.A. McKeown

February 11, 2018

Presentation Cardiovascular Interventions 2017

Laser Atherectomy

Presenter: William L. Lombardi

November 08, 2017

News Conference News TCT 2017

DARE Supports Drug-Coated Balloon as Alternative to DES for Any In-Stent Restenosis

Todd Neale

October 30, 2017

News Conference News ISET 2016

Drug-Coated Balloon Angioplasty Superior for In-Stent Restenosis of SFA, but Results Leave Much To Be Desired

Michael O'Riordan

February 10, 2016

News Industry News

Spectranetics Announces FDA Clearance of Turbo-Power(TM) Laser Atherectomy Catheter, Only Indicated Atherectomy Device for Treatment of In-Stent Restenosis

November 12, 2015

News Features

Drug-Coated Balloon Approvals Mark ‘Sea Change’ for Treatment of PAD

L.A. McKeown

January 28, 2015

News Daily News

DCBs Perform Better in De Novo Compared With Restenotic Femoropopliteal Lesions

Caitlin E. Cox

October 24, 2014

Advertisement

Brachytherapy Remains an Option for DES In-Stent Restenosis

Volume-Outcome Relationship Questioned in CHIP PCI for Stable Angina

Algorithm Aims to Help Operators Pair Laser Settings With PAD Lesion Type

CTO PCI: Lower Success, More Complications vs Other Complex PCI

PREPARE-CALC Shows Benefits of Rotational Atherectomy

REAL PTX: Head-to-Head DCB, DES Data in PAD Show Trend Favoring Stenting at 36 Months

Laser Atherectomy

DARE Supports Drug-Coated Balloon as Alternative to DES for Any In-Stent Restenosis

Drug-Coated Balloon Angioplasty Superior for In-Stent Restenosis of SFA, but Results Leave Much To Be Desired

Spectranetics Announces FDA Clearance of Turbo-Power(TM) Laser Atherectomy Catheter, Only Indicated Atherectomy Device for Treatment of In-Stent Restenosis

Drug-Coated Balloon Approvals Mark ‘Sea Change’ for Treatment of PAD

DCBs Perform Better in De Novo Compared With Restenotic Femoropopliteal Lesions

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content